McKesson

McKesson
Name	McKesson Corporation
Type	Public
Industry	Healthcare, Pharmaceuticals, Medical Supplies, Health Information Technology
Founded	1833
Founder	Charles Olcott, John McKesson
Headquarters	Irving, Texas, United States
Key people	Brian Tyler, Serena Huang
Revenue	US$...
Num employees	...

McKesson is an American healthcare company involved in pharmaceutical distribution, medical supplies, and health information technology. Founded in the 19th century, it grew into one of the largest global distributors serving pharmacies, hospitals, and clinics. The company has been central to debates involving United States Department of Justice, Food and Drug Administration, and pharmaceutical supply chain reforms.

History

McKesson traces origins to a 19th-century partnership between merchants in New York City and expanded through mergers and acquisitions across the 20th century. During the early 1900s it integrated wholesale operations with retail pharmacies in cities such as Chicago, Boston, and Philadelphia. The company’s mid-century growth intersected with regulatory developments involving the Pure Food and Drug Act and later interactions with agencies like the Federal Trade Commission and Securities and Exchange Commission. Strategic mergers connected it with firms in San Francisco, Los Angeles, and Houston, while international expansion touched markets in Canada, United Kingdom, and Mexico. Executive decisions in the 1980s and 1990s led to major corporate restructurings and technology investments influenced by trends from IBM, Microsoft, and Oracle Corporation. In the 21st century McKesson expanded into health IT through acquisitions and partnerships involving companies formerly associated with Eclipsys, RelayHealth, and other healthcare technology vendors.

Business Operations

McKesson operates broad distribution networks linking manufacturers such as Pfizer, Johnson & Johnson, Merck & Co., Novartis, and Roche to customers including independent pharmacies, chains like Walgreens Boots Alliance and CVS Health, hospital systems such as HCA Healthcare and CommonSpirit Health, and government purchasers including agencies analogous to the Department of Veterans Affairs. Logistics centers and fulfillment hubs coordinate with carriers like United Parcel Service and FedEx. The corporation’s enterprise software teams integrate with electronic health record vendors including Epic Systems Corporation, Cerner Corporation, and Allscripts Healthcare Solutions. Global supply chain linkages extend to manufacturers in China, India, and Germany.

Products and Services

McKesson’s offerings span pharmaceutical wholesale distribution, specialty drug services, medical-surgical supplies, and health information technology. Distribution channels move branded and generic drugs from firms such as Amgen, Bristol Myers Squibb, AstraZeneca, and Gilead Sciences. Specialty services include cold-chain logistics for biologics by manufacturers like Biogen and Regeneron. Medical-surgical inventories support hospitals and clinics using products from Medtronic, Baxter International, Stryker Corporation, and 3M. Software and analytics solutions address revenue cycle management, e-prescribing, and population health tied to systems developed by companies like Health Catalyst and Optum. Pharmacy automation platforms compete with technologies from BD (Becton, Dickinson and Company) and ScriptPro.

Corporate Governance and Leadership

Board composition and executive leadership reflect profiles common to large public corporations listed on the New York Stock Exchange and overseen by investors including indices such as the S&P 500. Past and present executives have had interactions with institutional shareholders like Vanguard Group, BlackRock, and State Street Corporation. Leadership decisions have involved corporate law counsel, investment banks such as Goldman Sachs and JPMorgan Chase, and auditors from the Big Four accounting firms including Deloitte and KPMG. Governance practices respond to regulatory frameworks like the Sarbanes–Oxley Act and investor activism exemplified by campaigns involving Carl Icahn and other activist investors in U.S. capital markets.

Controversies and Legal Issues

The company has been subject to high-profile legal scrutiny relating to distribution practices, regulatory compliance, and accounting matters. Litigation has involved state attorneys general coordinated similarly to multistate efforts seen in actions against manufacturers like Purdue Pharma and distributors in litigation that also targeted firms such as AmerisourceBergen and Cardinal Health. Regulatory investigations involved interactions with the Department of Justice and settlements analogous to those in cases brought under statutes like the Controlled Substances Act. Financial restatements and accounting controversies in prior decades prompted enforcement actions by the Securities and Exchange Commission and corporate governance reforms paralleling other corporate crises such as those involving Enron and WorldCom. Privacy and data-security inquiries connected to health IT operations are similar in nature to incidents faced by Anthem Inc. and Equifax.

Financial Performance and Market Position

McKesson ranks among the largest companies by revenue in the Fortune 500 and competes with major distributors like AmerisourceBergen and Cardinal Health for market share in pharmaceutical distribution. Financial performance is monitored by analysts at firms such as Morgan Stanley, Bank of America Merrill Lynch, and Credit Suisse and covered by media outlets including The Wall Street Journal, The New York Times, and Bloomberg News. Stock performance is followed by investors trading on exchanges where peers include Johnson & Johnson, CVS Health, and Walgreens Boots Alliance. The company’s market positioning is influenced by healthcare policy debates in venues such as the United States Congress and regulatory actions by the Food and Drug Administration and state regulatory authorities.

Category:Health care companies of the United States